DSpace About DSpace Software
 

Makerere University Research Repository >
College of Health Sciences >
School of Bio-Medical Sciences >
Research Articles (Bio-Medical) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1364

Title: Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis
Authors: Joloba, M. L.
Johnson, J. L.
Namale, A.
Morrissey, A.
Assegghai, A. E.
Mugerwa, R. D.
Ellner, J. J.
Eisenach, K. D.
Keywords: HIV
Mycobacterium tuberculosis
Culture
Colony forming units
Radiometric
Issue Date: 22-Jan-2000
Publisher: International Union Against Tuberculosis and Lung Disease
Citation: Joloba, M., Namale, A., Johnson, J.L., Morrissey, A., Assegghai, A. E., Mugerwa, R.D., Eisenach, K.D., Ellner, J.J. (2000). Quantitative sputum bacillary load during rifampin containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease, 4(6)
Abstract: SETTING: National Tuberculosis (TB) Treatment Centre, Mulago Hospital and Joint Clinical Research Centre, Kampala, Uganda. OBJECTIVE: To compare the quantitative sputum bacillary load between TB patients infected with the human immunodeficiency virus (HIV) and those non-infected, during treatment with standard short course chemotherapy(SCC). DESIGN: To compare clinical characteristics and quantitative sputum bacillary load as measured by quantitative acid-fast bacilli (AFB) smears, colony forming unit (cfu) assay and time until positive culture in the BACTEC® radiometric liquid system between 14 HIVinfected and 22 non-HIV-infected adults with initial episodes of smear-positive pulmonary TB at baseline and during treatment with standard four-drug SCC. RESULTS: Other than cavitation (P = 0.042) and adenopathy (P = 0.03), which were more common among non-HIV-infected and HIV-infected patients, respectively, there were no significant differences in baseline demographic, clinical, radiological and laboratory characteristics between the groups. Mean pretreatment sputum bacillary burden (6.5 ± 0.51 log10 AFB/ml, 5.91 ± 0.91 log10 cfu/ml and 1.8 ± 1.7 days until positive BACTEC® culture for HIV-infected patients and 6.32 ± 0.85 log10 AFB/ml, 5.58 ± 0.68 log10 cfu/ml and 1.9 ± 1.2 days until positive BACTEC® culture for non-HIVinfected patients) were comparable between HIV-infected and non-HIV-infected patients. Clinical and bacteriological responses to standard SCC and treatment outcome did not differ between the groups. CONCLUSION: Quantitative sputum bacillary load at baseline and during SCC did not differ significantly between HIV-infected and non-HIV-infected adults with initial episodes of smear-positive TB.
URI: http://hdl.handle.net/123456789/1364
Appears in Collections:Research Articles (Bio-Medical)

Files in This Item:

File Description SizeFormat
joloba-johnson-chs-res.pdf360KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2005 MIT and Hewlett-Packard - Feedback